Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fasting-Refeeding Impacts Immune Cell Dynamics and Mucosal Immune Responses.
Nagai M, Noguchi R, Takahashi D, Morikawa T, Koshida K, Komiyama S, Ishihara N, Yamada T, Kawamura YI, Muroi K, Hattori K, Kobayashi N, Fujimura Y, Hirota M, Matsumoto R, Aoki R, Tamura-Nakano M, Sugiyama M, Katakai T, Sato S, Takubo K, Dohi T, Hase K. Nagai M, et al. Among authors: komiyama s. Cell. 2019 Aug 22;178(5):1072-1087.e14. doi: 10.1016/j.cell.2019.07.047. Cell. 2019. PMID: 31442401 Free article.
α-Glucosidase inhibitors boost gut immunity by inducing IgA responses in Peyer's patches.
Hattori-Muroi K, Naganawa-Asaoka H, Kabumoto Y, Tsukamoto K, Fujisaki Y, Fujimura Y, Komiyama S, Kinashi Y, Kato M, Sato S, Takahashi D, Hase K. Hattori-Muroi K, et al. Among authors: komiyama s. Front Immunol. 2023 Nov 1;14:1277637. doi: 10.3389/fimmu.2023.1277637. eCollection 2023. Front Immunol. 2023. PMID: 38022673 Free PMC article.
Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis.
Komiyama S, Okusaka T, Maruki Y, Ohba A, Nagashio Y, Kondo S, Hijioka S, Morizane C, Ueno H, Sukeda A, Mizui T, Takamoto T, Nara S, Ban D, Esaki M, Hiraoka N, Shimada K. Komiyama S, et al. Intern Med. 2024 Apr 1;63(7):891-901. doi: 10.2169/internalmedicine.2016-23. Epub 2023 Aug 23. Intern Med. 2024. PMID: 37612088 Free PMC article.
Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh Class A Liver function: A Pilot Study.
Wang F, Numata K, Komiyama S, Miwa H, Sugimori K, Ogushi K, Moriya S, Nozaki A, Chuma M, Ruan L, Maeda S. Wang F, et al. Among authors: komiyama s. Front Oncol. 2022 May 4;12:843680. doi: 10.3389/fonc.2022.843680. eCollection 2022. Front Oncol. 2022. PMID: 35600400 Free PMC article.
280 results